Brexpiprazole in Borderline Personality Disorder

NCT03418675 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Borderline Personality Disorder

Interventions

DRUG: Rexulti
DRUG: Placebo

Sponsor

University of Chicago

Collaborators

[object Object]